Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (2469)	2/22/1998 5:20:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 7041

Note Zonagen's lie: <<Phentolamine has been approved by the FDA for the treatment of hypertension and for use in the diagnosis of certain tumors of the adrenal gland, and has been used "off-label" by urologists, either alone or in combination with other drugs, in penile needle injection therapies for the treatment of erectile dysfunction. >> Phentolamine is not used alone for the treatment of ED. This is a lie. Phentolamine does not produce erections. Phentolamine is a generic drug which is ineffective in the treatment of ED. This lie is not surprising since Zonagen's mangement has lied again and again and again. Zonagen is a fraudulent scheme to separate small investors from their money. Zonagen has not nor will ever deliver any earnings or value to its shareholders. Zonagen's stock is grossly overvalued and will soon trade in the gutter.